Page 7 - Lupin

Lupin slips 4% as Goa plant gets 7 observations from the USFDA

These observations which has been under regulatory oversight for 4 years, and can impact investor sentiment although revenue will not be impacted in the near term, ICICI Securities note stated

Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed

Says confident of resolving matter, does not share nature of observations

Lupin launches generic Duexis tablets in US to treat rheumatoid arthritis

Drug firm Lupin on Wednesday said it has launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and osteoarthritis in the US market.

Lupin bets big on inhalation segment, plans to enter Chinese market

Lupin's portfolio and pipeline addresses 70 per cent of the entire market

Lupin gets tentative nod from USFDA to market partial-onset seizures drug

Drug firm Lupin on Monday said it has received tentative nod from the US health regulator to market its generic Brivaracetam tablets used for the treatment of partial-onset seizures

Lupin falls 7% post Q1 results, hits over three month low

The pharmaceutical company reported a disappointing April-June quarter (Q1FY22) performance on the margins front

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Lupin launches generic antifungal Tavaborole Topical Solution in US market

Drug maker Lupin on Tuesday said it has launched antifungal product Tavaborole Topical Solution in the US market.

Stocks to watch: Dodla Dairy, KIMS, Barbeque Nation, Thyrocare, SBI, Lupin

Realty firm Ashiana Housing on Saturday reported a consolidated net loss of Rs 5.2 crore for the quarter ending March. Its net loss stood at Rs 8.63 crore in the year-ago period

Trading calls by Ajit Mishra of Religare Broking: Buy Britannia, Lupin

Britannia has been trading in a broader consolidation range of Rs 3,350-3,840 for the last one year and is currently hovering in the middle

Stocks to watch: ICICI Bank, Dish TV, Adani Ports, Jubilant Pharmova, Lupin

Dr Reddy's Laboratories (DRL) on Tuesday said it has been asked to pay $46.25 million to Australia-based Hatchtech Pty Ltd as part of an asset purchase agreement between the two parties in 2015

Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit

Lupin said the company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility

Lupin gets warning letter from US health regulator for Somerset facility

The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility, it said

Stocks to watch: M&M, PNB, Bharat Forge, Lupin, rate sensitive stocks

ABB Power Products on Thursday said it has resumed operations at its manufacturing facility in Bengaluru from May 28

Lupin to enter digital healthcare space; to provide platform for doctors

Lupin said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients.

This Rakesh Jhunjhunwala-owned pharma stock hits over 4-year high

Lupin rose 4 per cent to Rs 1,258.70 on the BSE in intra-day trade on Wednesday, a level that was last seen in May 2017

Lupin shares slide 4% amid profit booking post March quarter results

During the past six trading days, Lupin outperformed the market and surged 15 per cent as compared to a per cent rise in the S&P BSE Sensex till Wednesday

Lupin willing to take partners to bring mRNA Covid-19 vaccines to India

Executive says company is looking for tie-ups to bring in drugs like Remdesivir

Lupin Q4 net profit up 18% at Rs 460 cr; FY21 profit at Rs 1,216 cr

Drug maker Lupin on Thursday reported an 18 per cent increase in its consolidated net profit at Rs 460 crore for the fourth quarter, driven by robust sales across domestic and international markets

Lupin soars 8%, hits over three-year high on heavy volumes

The stock surpassed its previous high of Rs 1,121.85 touched on September 2020 and was trading at the highest level since July 2017